Rezaie Payam, Male David
Department of Neuropathology, Institute of Psychiatry, SE5 8AF, UK.
J Hist Neurosci. 2002 Dec;11(4):325-74. doi: 10.1076/jhin.11.4.325.8531.
More than a century and a half has elapsed since the first accounts of mesodermal phagocytic elements were proposed within the central nervous system. Over the intervening decades, body and substance were added to this concept through the advancement of histological techniques at the disposal of the researcher and the acute and keen-minded skills of the pathologist. Notable among these pioneering efforts were the contributions of W. Ford Robertson, Santiago Ramon y Cajal, Pio del Rio-Hortega and Wilder Penfield amongst an entire cavalcade of other noteworthy figures. The term 'mesoglia' and 'third element of the nervous system' was bestowed upon these cells towards the beginning of the twentieth century to account for their separate origins from neurons and macroglia. It was later amended by del Rio-Hortega in 1919, to 'microglia' in order to further discriminate between true mesodermal elements and oligodendrocytes, previously regarded as a component of 'mesoglia'. This particular contention sparked much controversy among del Rio-Hortega's peers and resulted in an escalation of fruitful research throughout Europe that eventually declined up to the outbreak of the Second World War. The post-war years were a period of the 'dark ages' that cast doubt on the very existence and nature of microglia, until the 'renaissance' of research was once again rejuvenated in the 1960s, by a new cohort of intrigued minds: Cammermeyer, Blinzinger, Kreutzberg and others who saw in the 'third element' the potential that is now commonly ascribed to microglia: the intrinsic immune effector cells of the CNS. It is now universally accepted that microglia are involved as the first line of rapid defence in any pathology of the nervous system, and as such, present a diagnostic tool for the neuropathologist. Although our knowledge of microglia stems from an extensive body of work conducted over the last two decades, much of the earlier work (pre-1960s) has remained somewhat obscure. This is partly accountable due to the limited availability of translated works, and additionally to the lack of a compendium of these articles. This paper will present a comprehensive overview of the pioneering research on mononuclear phagocytes within the central nervous system, which has direct bearing on our present-day understanding of the concept of microglia.
自首次提出中枢神经系统中存在中胚层吞噬细胞以来,一个半多世纪已经过去了。在这几十年间,随着研究人员可利用的组织学技术的进步以及病理学家敏锐的洞察力,这个概念在实体和物质层面都得到了补充。在这些开创性的努力中,W. 福特·罗伯逊、圣地亚哥·拉蒙·伊·卡哈尔、皮奥·德尔·里奥 - 霍特加和怀尔德·彭菲尔德等众多杰出人物都做出了贡献。在20世纪初,“中神经胶质细胞”和“神经系统的第三种成分”这一术语被赋予这些细胞,以说明它们与神经元和大胶质细胞的不同起源。后来在1919年,德尔·里奥 - 霍特加将其修正为“小胶质细胞”,以便进一步区分真正的中胚层成分和少突胶质细胞,少突胶质细胞此前被视为“中神经胶质细胞”的一个组成部分。这一特殊的争论在德尔·里奥 - 霍特加的同行中引发了诸多争议,并导致了整个欧洲富有成效的研究的升级,这种研究在第二次世界大战爆发前最终有所减少。战后的岁月是一个“黑暗时代”,人们对小胶质细胞的存在和性质都产生了怀疑,直到20世纪60年代,研究再次“复兴”,一群新的好奇的研究者出现了:卡默迈尔、布林津格、克罗伊茨贝格等人,他们在“第三种成分”中看到了如今通常归因于小胶质细胞的潜力:中枢神经系统的固有免疫效应细胞。现在人们普遍认为,小胶质细胞在神经系统的任何病理过程中都作为快速防御的第一线发挥作用,因此,它为神经病理学家提供了一种诊断工具。尽管我们对小胶质细胞的认识源于过去二十年中进行的大量工作,但许多早期工作(20世纪60年代之前)仍然有些模糊不清。部分原因是翻译作品的可得性有限,此外还缺乏这些文章的汇编。本文将全面概述中枢神经系统中单核吞噬细胞的开创性研究,这与我们当今对小胶质细胞概念的理解直接相关。